| Announce Date | 08/12/2025 |
| EPS Normalized Actual | $-0.49136 (Miss by $-0.36136) |
| EPS GAAP Actual | $-0.49136 (Miss by $-0.36136) |
| Revenue Actual | $0.007575B |
| Revenue Surprise | Beat by $7.575M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.14 |
| EPS GAAP Estimate | $-0.14 |
| Revenue Estimate | $0.015309B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | -0.31 | -5.73 | -0.31 | -0.31 | 1 |
| Dec 2024 | -0.86769 | -2.05 | -0.86769 | -0.86769 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.67 | 0.85 | 0.007575B | 34.77% | -1.69M |
| FQ2 2025 (Jun 2025) | -0.49 | -0.36 | 0.006378B | 65.99% | 0.48M |
| FQ1 2025 (Mar 2025) | -0.18 | -0.18 | 0.005514B | 100% | 5.51M |
| FQ2 2023 (Jun 2023) | 0.0336 | 0.0336 | 0B | NAN% | 0M |
| FQ3 2023 (Sep 2023) | -0.051 | -0.051 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.34 | -0.34 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | 0.0701 | 0.0701 | 0.002169B | 100% | 2.17M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.14
Consensus Revenue Estimates
0.015309B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.15 | -- | -0.15 | -0.15 | 1 |
| FQ3 2026 (Sep 2026) | -0.04 | 1775 | -0.04 | -0.04 | 1 |
| FQ2 2026 (Jun 2026) | -0.04 | -1125 | -0.04 | -0.04 | 1 |
| FQ1 2026 (Mar 2026) | -0.14 | -28.57 | -0.14 | -0.14 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | 48.08 | 0.01B | 0.01B | 1 |
| FQ2 2026 (Jun 2026) | 0.01B | 55.4 | 0.01B | 0.01B | 1 |
| FQ1 2026 (Mar 2026) | 0.02B | 63.98 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
3
Revenue # of Misses
1
Revenue # of in-lines
4
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.18 | 0.67 | 0.85 | 126.87% |
| FQ2 2025 (Jun 2025) | -0.13 | -0.49 | -0.36 | 73.47% |
| FQ1 2025 (Mar 2025) | -0.18 | -0.18 | 100% | |
| FQ2 2023 (Jun 2023) | 0.0336 | 0.0336 | 100% | |
| FQ3 2023 (Sep 2023) | -0.051 | -0.051 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | -0.34 | -0.34 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0701 | 0.0701 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $0.01B | $-1.69M | -22.24% |
| FQ2 2025 (Jun 2025) | $0.01B | $0.01B | $0.48M | 7.49% |
| FQ1 2025 (Mar 2025) | $0B | $0.01B | $5.51M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $2.17M | 100% |